CDT Equity Inc. (CDT): Cash & Equivalents
$1.51M
As of 2025-12-31
$747.0K
As of 2026-06-30
+63.4%
3-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.51M | +172.4% | 2026-04-15, Balance as of period end |
| 2024-12-31 | $554.0K | -86.9% | 2026-04-15, Balance as of period end |
| 2023-12-31 | $4.23M | n/m | 2025-03-28, Balance as of period end |
| 2022-12-31 | $345.8K | +612.1% | 2023-03-28, Balance as of period end |
| 2021-12-31 | $48.6K | n/a | 2023-03-28, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| CDT Equity Inc. (CDT) | 2025-12-31 | $1.51M | +172.4% |
| AEON Biopharma, Inc. (AEON) | 2025-12-31 | $3.01M | n/m |
| Ernexa Therapeutics Inc. (ERNA) | 2024-12-31 | $1.73M | -77.2% |
| 60 Degrees Pharmaceuticals, Inc. (SXTP) | 2025-12-31 | $1.51M | -9.0% |
| Polaryx Therapeutics, Inc. (PLYX) | 2025-12-31 | $5.14M | +11.3% |
| Greenwich LifeSciences, Inc. (GLSI) | 2025-12-31 | $6.18M | +51.0% |
| Petros Pharmaceuticals, Inc. (PTPI) | 2025-12-31 | $5.14M | +198.9% |
| GeoVax Labs, Inc. (GOVX) | 2025-12-31 | $3.09M | -44.0% |
| Azitra, Inc. (AZTR) | 2025-12-31 | $2.07M | -54.6% |
Compare CDT, AEON, ERNA, SXTP side by side · Screen every company in Pharmaceutical Preparations ↗